Boost your SEO with Backlinks that are worth it

Turn scattered startup information into focused action.

Submit your startup to 120+ top directories.

Edit

Upgrade

Immunologix

Immunologix develops and produces antibody-based therapeutics against viral, bacterial, and tumor antigens, as well as human auto antigens.

Acquired by Intrexon Corporation on October 24, 2011

Website: https://www.immunologix.com

Founded: September 28, 2008

Social:

Add Competitor

Startup	Industry	Description
24Genetics	Pharmaceuticals & Biotechnology	DNA Testing for Ancestry and wellness - 24Genetics is a European Biotechnology startup tha ...
Turn Biotechnologies	Pharmaceuticals & Biotechnology	Fighting age-related disease at the cellular level - Turn Biotechnologies, Inc. is a Silicon Valley-bas ...
NeuroX1	Pharmaceuticals & Biotechnology	The new standard in computational neuroscience - NeuroX1 is a computational drug design company bui ...

View more competitors»

Date	Round	Amount	Investors
Jul 20, 2011	Venture	$ 250,948
Aug 13, 2010	Venture	$ 890,168
Mar 12, 2010	Venture	$ 200,000	SC Launch

Date	Acquired	Amount
There are no acquisitions.

Product	Stage	Description
There are no products.

Person	Role	Period
Douglas Carnes	Founder	Unknown to Unknown
Ryan N. Fiorini	Founder	Unknown to Unknown